Tridem Bioscience is focusing on the discovery and development of innovative active immunotherapies based on our proprietary WISIT (WIn the Skin Immune system Trick) technology.
We aim to realize this novel vaccine concept using Parkinson’s disease (PD) as our first indication. PD is the major representative of synucleopathies, a group of neurodegenerative diseases with high-unmet medical need.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Rudolf Waisenhorngasse, Wien,1230,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.tridem.at
- HQ
- Wien
Tridem Bioscience Questions
Tridem Bioscience's website is http://www.tridem.at
Tridem Bioscience's LinkedIn profile is https://at.linkedin.com/company/tridem-bioscience-gmbh-cokg
Tridem Bioscience has
3 employees.
View email and phone details for 3
employees at Tridem Bioscience.
Tridem Bioscience's industry is
Biotechnology Research
Tridem Bioscience's top competitors are
Novasign,
Bespark*bio,
Abs Biotechnologies Gmbh,
Acib Gmbh,
Oncoone,
Valanx Biotech,
Novoarc Gmbh,
Calyxha Biotechnologies,
Velalabs,
Ygion Biomedical.
Tridem Bioscience's categories are Biotechnology Research
Tridem Bioscience's founding year is 2020
